Alembic Drug Patent Portfolio
Alembic owns 1 orange book drug protected by 7 US patents Given below is the list of Alembic's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10238634 | Aqueous-based metronidazole gel formulations | 28 Jun, 2032 | Active |
| US10596155 | Aqueous-based metronidazole gel formulations | 28 Jun, 2032 | Active |
| US8946276 | High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis | 28 Jun, 2032 | Active |
| US9198858 | Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations | 28 Jun, 2032 | Active |
| US8658678 | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water | 27 Jun, 2028 | Active |
| US7893097 | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water | 19 Feb, 2028 | Active |
| US8877792 | Compositions for increasing solubility of azole drug compounds that are poorly soluble in water | 02 Feb, 2028 | Active |
Latest Legal Activities on Alembic's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Alembic.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 23 Jul, 2025 | US8658678 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 25 Sep, 2023 | US10596155 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 01 Jun, 2023 | US9198858 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 26 Sep, 2022 | US10238634 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 03 Aug, 2022 | US8946276 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Jul, 2022 | US7893097 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Apr, 2022 | US8877792 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 27 Jul, 2021 | US8658678 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 Mar, 2020 | US10596155 |
|
Recordation of Patent Grant Mailed
Critical
| 24 Mar, 2020 | US10596155 |
|
Issue Notification Mailed
Critical
| 04 Mar, 2020 | US10596155 |
| Dispatch to FDC | 20 Feb, 2020 | US10596155 |
|
Application Is Considered Ready for Issue
Critical
| 14 Feb, 2020 | US10596155 |
|
Issue Fee Payment Received
Critical
| 07 Feb, 2020 | US10596155 |
|
Issue Fee Payment Verified
Critical
| 07 Feb, 2020 | US10596155 |
Alembic's Family Patents
Recent FDA approvals and tentative approvals for Alembic
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Binimetinib |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 18 Jun, 2026 |
| Bosutinib Monohydrate |
SUPPL-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Manufacturing (CMC) | 12 Jun, 2026 |
| Ribociclib |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 10 Jan, 2024 |
Alembic Drug List
Given below is the complete list of Alembic's drugs and the patents protecting them.
1. Nuvessa
Nuvessa is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10238634 | Aqueous-based metronidazole gel formulations |
28 Jun, 2032
(6 years from now)
| Active |
| US10596155 | Aqueous-based metronidazole gel formulations |
28 Jun, 2032
(6 years from now)
| Active |
| US8946276 | High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
28 Jun, 2032
(6 years from now)
| Active |
| US9198858 | Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations |
28 Jun, 2032
(6 years from now)
| Active |
| US8658678 | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
27 Jun, 2028
(2 years from now)
| Active |
| US7893097 | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
19 Feb, 2028
(1 year, 7 months from now)
| Active |
| US8877792 | Compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
02 Feb, 2028
(1 year, 7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nuvessa's drug page